Since we found a large proportion of the metastatic CCAs exhibited simultaneous over-expression of Hic-5 and over-activation of Src, AKT, and JNK, it is very probable that they work together to trigger metastatic signaling for CCA progression. The gene discussed is AKT1; the disease is cholangiocarcinoma.